Literature DB >> 33840587

Knockdown of lncRNA PVT1 attenuated macrophage M1 polarization and relieved sepsis induced myocardial injury via miR-29a/HMGB1 axis.

Yuan-Yuan Luo1, Zhong-Qi Yang2, Xin-Feng Lin1, Feng-Li Zhao1, Hai-Tao Tu3, Ling-Jun Wang4, Min-Yong Wen5, Shao-Xiang Xian6.   

Abstract

BACKGROUND: LncRNA PVT1 was reported to be elevated in septic myocardial tissue. The underlying mechanism by which PVT1 aggravated sepsis induced myocardial injury needs further investigation.
METHODS: Mice was subjected to LPS injection to mimic in vivo sepsis model. HE staining was applied to observe tissue injury. Cardiac function of mice was determined by echocardiography. Bone marrow derived macrophage (BMDM) was used to confirm the regulatory effect of PVT1 in macrophage polarization. Western blotting or qRT-PCR were performed to evaluate protein or mRNA levels, respectively. ELISA was conducted to determine cytokine levels. Interaction between PVT1 and miR-29a, miR-29a and HMGB1 were accessed by dual luciferase assay.
RESULTS: Expression of PVT1 was elevated in myocardial tissue and heart infiltrating macrophages of sepsis mice. PVT1 knockdown alleviated LPS induced myocardial injury and attenuated M1 macrophage polarization. The mechanic study suggested that PVT1 targeted miR-29a, thus elevated expression of HMGB1, which was repressed by miR-29a targeting. The effect of PVT1 on M1 macrophage polarization was dependent on targeting miR-29a.
CONCLUSION: PVT1 promoted M1 polarization and aggravated LPS induced myocardial injury via miR-29a/HMGB1 axis.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  HMGB1; Macrophage polarization; Myocardial injury; Sepsis; lncRNA PVT1

Mesh:

Substances:

Year:  2021        PMID: 33840587     DOI: 10.1016/j.cyto.2021.155509

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  9 in total

1.  Protective Role of lncRNA TTN-AS1 in Sepsis-Induced Myocardial Injury Via miR-29a/E2F2 Axis.

Authors:  Xinghua Pei; Yanhong Wu; Haiming Yu; Yuji Li; Xu Zhou; Yanjun Lei; Wu Lu
Journal:  Cardiovasc Drugs Ther       Date:  2021-09-14       Impact factor: 3.727

2.  Long non-coding RNA ZFY-AS1 represses periodontitis tissue inflammation and oxidative damage via modulating microRNA-129-5p/DEAD-Box helicase 3 X-linked axis.

Authors:  Lin Cheng; YuLing Fan; Jue Cheng; Jun Wang; Qingmei Liu; ZhiYuan Feng
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

Review 3.  High Mobility Group Proteins in Sepsis.

Authors:  Guibin Liang; Zhihui He
Journal:  Front Immunol       Date:  2022-06-02       Impact factor: 8.786

Review 4.  Regulatory Mechanism of lncRNAs in M1/M2 Macrophages Polarization in the Diseases of Different Etiology.

Authors:  Ping Jiang; Xiaopeng Li
Journal:  Front Immunol       Date:  2022-01-25       Impact factor: 7.561

Review 5.  Research Progress on the Mechanism of Sepsis Induced Myocardial Injury.

Authors:  Cheng-Fei Bi; Jia Liu; Li-Shan Yang; Jun-Fei Zhang
Journal:  J Inflamm Res       Date:  2022-07-26

6.  Long non-coding RNA PVT1 regulates LPS-induced acute kidney injury in an in vitro model of HK-2 cells by modulating the miR-27a-3p/OXSR1 axis.

Authors:  Qian Yang; Qi Sun; Ping Jin
Journal:  Exp Ther Med       Date:  2022-07-01       Impact factor: 2.751

Review 7.  Applications of machine learning in tumor-associated macrophages.

Authors:  Zhen Li; Qijun Yu; Qingyuan Zhu; Xiaojing Yang; Zhaobin Li; Jie Fu
Journal:  Front Immunol       Date:  2022-09-23       Impact factor: 8.786

Review 8.  lncRNA PVT1: a novel oncogene in multiple cancers.

Authors:  Ruiming Li; Xia Wang; Chunming Zhu; Kefeng Wang
Journal:  Cell Mol Biol Lett       Date:  2022-10-04       Impact factor: 8.702

Review 9.  Regulatory Role of Non-Coding RNAs on Immune Responses During Sepsis.

Authors:  Soudeh Ghafouri-Fard; Tayyebeh Khoshbakht; Bashdar Mahmud Hussen; Mohammad Taheri; Normohammad Arefian
Journal:  Front Immunol       Date:  2021-12-09       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.